Gerhard Mayr

Former Executive Vice President, Pharmaceutical Operations at Eli Lilly & Company

Gerhard Mayr

Gerhard Mayr

Former Executive Vice President, Pharmaceutical Operations at Eli Lilly & Company

Biography

Gerhard N. Mayr is on the board of Almirall SA, Project HOPE-The-People-To-People HealthFoundation, Inc., GVK Biosciences Pvt Ltd. and Vienna Science, Research & Technology Foundation and Member-Patrons Circle Division at INSEAD. He previously held the position of Independent Non-Executive Director at UCB SA, Director at Lonza Group AG, Member of U.S.-Egypt Presidents' Council and Executive Vice President-Pharmaceutical Operations at Eli Lilly & Co. Mr. Mayr received an MBA from Stanford University and a graduate degree from Swiss Federal Institute of Technology.

Overview
Career Highlights

Lilly Intercontinental
Lilly International

RelSci Relationships

1928

Number of Boards

13

Birthday

1946

Age

73

Relationships
RelSci Relationships are individuals Gerhard Mayr likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman of the Executive Committee, Chief Executive Officer, Executive Director at UCB S. A.

Relationship likelihood: Strong

Chief Executive Officer & Director at Almirall SA

Relationship likelihood: Strong

Professional at Academy of Medical Sciences

Relationship likelihood: Strong

Corporate Director & General Counsel at Almirall SA

Relationship likelihood: Strong

Former Chief Executive Officer & Executive Director at UCB S. A.

Relationship likelihood: Strong

Former Chief Executive Officer at Merck & Co., Inc.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Almirall SA

Relationship likelihood: Strong

Former Executive Vice President & Chief Financial Officer at Ferring Holding SA

Relationship likelihood: Strong

Former Chief Executive Officer & Managing Director at Ranbaxy Laboratories Limited

Relationship likelihood: Strong

Chief Health Officer at Project HOPE

Relationship likelihood: Strong

Paths to Gerhard Mayr
Potential Connections via
Relationship Science
You
Gerhard Mayr
Former Executive Vice President, Pharmaceutical Operations at Eli Lilly & Company
Education
MBA
Class of 1972

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Master's in Chemical Engineering
Class of 1969

École Polytechnique Fédérale de Lausanne

Memberships
Member
1999 - 2004
Career History
President
1997 - 1999
President
1993 - 1997
Executive Vice President, Pharmaceutical Operations
1972 - 2004

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Boards & Committees
Member, Audit Committee
2006 - 2013

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Director
Prior

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Director
1995 - 2002

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association founded in 1978 representing the research-based pharmaceutical industry operating in Europe.

Chairman of the International Executive Committee
Prior

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country's biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 +
2015

Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerhard Mayr. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerhard Mayr's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerhard Mayr.